Home > Blog

Blog | Veristat, The Science-First CRO

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Sign Up Today

Regulatory Submissions

2 min read

Demystifying eCTD 4.0: What You Need to Know

Electronic Common Technical Document (eCTD) submissions have transformed sponsor companies' interactions with global health authorities. Over the past two decades, eCTDs have evolved from a basic electronic substitute for paper to a robust, standardized...

READ MORE

2 min read

Mastering a Global Approach to Medical Writing

Medical writing plays an essential role in clinical development and regulatory approval. As scientific advancements grow more complex, well-structured documentation ensures the success of clinical trials, facilitates regulatory review, and accelerates...

READ MORE

3 min read

Planning Your IND: When and Why to Engage the FDA

Many sponsors underestimate how much support the Food and Drug Administration (FDA) can offer during early drug development, often believing they need more data than is truly required before engaging. But once your proof-of-concept data, clinical...

READ MORE

3 min read

Monthly FDA Guidance and Regulatory News Review - May 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

5 min read

Multi-Regional Clinical Trials: Key Recommendations for a Global Clinical Development Program

The FDA recently released a draft guidance on the use of multi-regional clinical trials (MRCTs) in oncology research. A well-planned MRCT can be an efficient approach to the global clinical development of a novel product, allowing for access to a wider...

READ MORE

3 min read

Ensuring Patient Safety and Data Integrity with Veristat’s DMC Expertise

Data Monitoring Committees (DMCs) play a vital role in clinical trials by providing independent oversight to ensure patient safety, maintain scientific validity, and uphold data integrity. With clinical trials becoming increasingly complex, especially...

READ MORE

3 min read

Monthly FDA Guidance and Regulatory News Review - April 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA) that are pertinent to the governance of clinical trials and drug, biologic, or medical device development...

READ MORE

1 min read

Staying the Course: What FDA Staffing Reductions Mean for Drug Development Today

The U.S. Food and Drug Administration (FDA) is undergoing significant change. Recent announcements have highlighted budget constraints, hiring freezes, and reductions in force (RIFs) across federal health agencies, including the FDA. These shifts have...

READ MORE

2 min read

Unlocking the Promise of Radiopharmaceuticals: Safety, Strategy & Innovation in Clinical Trials

We’re hearing more and more about the value of radiopharmaceuticals in medicine today—but what does it take to ensure their safe and effective development throughout a clinical trial?

READ MORE

2 min read

Building Confidence in RWE: Delivering Smarter Regulatory Strategies

Real-world evidence (RWE) offers the potential to serve as a valuable tool in regulatory decision-making, offering insights derived from the real world that can complement traditional clinical trials. By capturing data from diverse sources such as...

READ MORE